Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 702天前

Horizon Says UPLIZNA Approved By Brazilian Health Regulatory Agency As Monotherapy For NMOSD

Biotechnology company Horizon Therapeutics plc (HZNP) announced Tuesday that the Brazilian Health Regulatory Agency (ANVISA) has approved UPLIZNA as a monotherapy for the treatment of adult patients with NMOSD who are AQP4-IgG+.

RTTNews | 957天前

Horizon Says Phase 2 Trial Of Dazodalibep To Treat Sjögren's Syndrome Met Primary Endpoint

Horizon Therapeutics plc (HZNP) announced Monday that its Phase 2 trial evaluating dazodalibep for the treatment of Sjögren's syndrome met the primary endpoint in patients with moderate-to-high systemic disease activity. Sjögren's syndrome is a disease with no FDA-approved treatments available.

RTTNews | 1056天前

Horizon Therapeutics To Buyback Up To $500 Mln Of Ordinary Shares

Biotechnology company Horizon Therapeutics plc (HZNP) today announced that its Board of Directors authorized the repurchase of up to $500 million of the Company's ordinary shares.

RTTNews | 1059天前

European Economic News Preview: Eurozone Sentix Investor Confidence Due

Investor confidence from the euro area and unemployment from Spain are the top economic news due on Monday. At 2.30 am ET, the Federal Statistical Office publishes Swiss inflation data for July. Economists forecast consumer prices to rise 0.1 percent year-on-year, the same rate of increase as seen in June.

RTTNews | 35分钟前

European Shares Seen Tad Higher At Open

European stocks may open on a positive note Monday as investors keep an eye on the latest batch of earnings and watch further developments on the tariff front.

RTTNews | 52分钟前

Sensex, Nifty Give Up Early Gains; IT And Pharma Stocks Drag

Indian shares were little changed on Monday, giving up some early gains, with rising trade tensions with the U.S., mixed earnings results and continued foreign fund outflows keeping investors on edge.

RTTNews | 2小时11分钟前

Australian Market Extends Early Losses In Mid-market

The Australian stock market is extending its early losses in choppy mid-market trading on Monday, also adding to the losses in the previous two sessions, following the broadly negative cues from Wall Street on Friday. The benchmark S&P/ASX 200 index is falling below the 8,650.00 level, with weakness in energy, financial and technology stocks partially offset by strong gains in mining stocks.

RTTNews | 2小时50分钟前

EURUSD	1.15698	GBPUSD	1.32772	AUDUSD	0.64771
USDJPY	147.686	USDCAD	1.37808	USDCHF	0.80728

Advertisement

Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab